NCT06620211View on ClinicalTrials.gov

Evaluation of the Safety, Performance, and Tolerability of the Sacromesh® Medical Device in the Treatment of Prolapse by Promontofixation in a Population of Patients Followed Over the Long Term.

CompletedOBSERVATIONAL
Enrollment

290

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

October 19, 2023

Study Completion Date

October 19, 2023

Conditions
Prolapse; Female
Interventions
PROCEDURE

promontofixation, prolapse cure

Patient who underwent surgery to place the Sacromesh® medical device (promontofixation) for a prolapse cure, between 2009 and 2018

Trial Locations (1)

59117

Cousin Biotech, Wervicq-Sud

Sponsors

Lead Sponsor

Cousin Biotech
All Listed Sponsors
lead

Cousin Biotech

INDUSTRY

NCT06620211 - Evaluation of the Safety, Performance, and Tolerability of the Sacromesh® Medical Device in the Treatment of Prolapse by Promontofixation in a Population of Patients Followed Over the Long Term. | Biotech Hunter | Biotech Hunter